Bluegrass Vascular Technologies Inc. – Trademark Portfolio

Entity Type: 03

Bluegrass Vascular Technologies Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include SURFACER, INSIDE-OUT, DON'T GO LEFT, and RESTORE ACCESS. PRESERVE OPTIONS.. The owner is based in San Antonio, TX.

Suite 308

12500 Network Boulevard

San Antonio, TX 78249

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bluegrass Vascular Technologies Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Bluegrass Vascular Technologies Inc. have?

Bluegrass Vascular Technologies Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.

What trademark classes does Bluegrass Vascular Technologies Inc. file in?

Bluegrass Vascular Technologies Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Bluegrass Vascular Technologies Inc.'s most well-known trademarks?

Bluegrass Vascular Technologies Inc.'s registered trademark portfolio includes well-known marks such as SURFACER, INSIDE-OUT, DON'T GO LEFT, and RESTORE ACCESS. PRESERVE OPTIONS.. These are among 4 currently registered trademarks in the portfolio.

What is Bluegrass Vascular Technologies Inc.'s trademark registration success rate?

Bluegrass Vascular Technologies Inc. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.